Capricor Therapeutics Stock Price Prediction
| CAPR Stock | USD 5.01 0.04 0.79% |
Oversold Vs Overbought
59
Oversold | Overbought |
Capricor Therapeutics stock price prediction is an act of determining the future value of Capricor Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Capricor Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Capricor Therapeutics and does not consider all of the tangible or intangible factors available from Capricor Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Capricor Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Capricor Therapeutics' stock price prediction:EPS Estimate Next Quarter (0.30) | EPS Estimate Current Year (0.96) | EPS Estimate Next Year 0.1 | Wall Street Target Price 21 | EPS Estimate Current Quarter (0.09) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Capricor Therapeutics based on different types of headlines from major news networks to social media. The Capricor stock price prediction module provides an analysis of price elasticity to changes in media outlook on Capricor Therapeutics over a specific investment horizon. Using Capricor Therapeutics hype-based prediction, you can estimate the value of Capricor Therapeutics from the perspective of Capricor Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Capricor Therapeutics using Capricor Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Capricor using crowd psychology based on the activity and movement of Capricor Therapeutics' stock price.
Capricor Therapeutics Implied Volatility | 129.47 |
Capricor Therapeutics' implied volatility exposes the market's sentiment of Capricor Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Capricor Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Capricor Therapeutics stock will not fluctuate a lot when Capricor Therapeutics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Capricor Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Capricor Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Capricor because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Capricor Therapeutics after-hype prediction price | USD 5.1 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Capricor |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Capricor Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Capricor Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Capricor Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Capricor Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Capricor Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Capricor Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Capricor Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Capricor Therapeutics' historical news coverage. Capricor Therapeutics' after-hype downside and upside margins for the prediction period are 0.92 and 9.28, respectively. We have considered Capricor Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Capricor Therapeutics is slightly risky at this time. Analysis and calculation of next after-hype price of Capricor Therapeutics is based on 3 months time horizon.
Capricor Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Capricor Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Capricor Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Capricor Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.42 | 4.21 | 0.10 | 0.04 | 9 Events / Month | 10 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
5.01 | 5.10 | 1.80 |
|
Capricor Therapeutics Hype Timeline
Capricor Therapeutics is currently traded for 5.01. The entity has historical hype elasticity of 0.1, and average elasticity to hype of competition of -0.04. Capricor is projected to increase in value after the next headline, with the price projected to jump to 5.1 or above. The average volatility of media hype impact on the company the price is over 100%. The price gain on the next news is projected to be 1.8%, whereas the daily expected return is currently at 0.42%. The volatility of related hype on Capricor Therapeutics is about 4066.48%, with the expected price after the next announcement by competition of 4.97. The company reported the previous year's revenue of 25.18 M. Net Loss for the year was (22.29 M) with profit before overhead, payroll, taxes, and interest of 1.75 M. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Capricor Therapeutics Basic Forecasting Models to cross-verify your projections.Capricor Therapeutics Related Hype Analysis
Having access to credible news sources related to Capricor Therapeutics' direct competition is more important than ever and may enhance your ability to predict Capricor Therapeutics' future price movements. Getting to know how Capricor Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Capricor Therapeutics may potentially react to the hype associated with one of its peers.
Capricor Therapeutics Additional Predictive Modules
Most predictive techniques to examine Capricor price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Capricor using various technical indicators. When you analyze Capricor charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Capricor Therapeutics Predictive Indicators
The successful prediction of Capricor Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Capricor Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Capricor Therapeutics based on analysis of Capricor Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Capricor Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Capricor Therapeutics's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 5.07 | 3.57 | 3.98 | 3.78 | Receivables Turnover | 0.63 | 4.65 | 2.43 | 2.31 |
Story Coverage note for Capricor Therapeutics
The number of cover stories for Capricor Therapeutics depends on current market conditions and Capricor Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Capricor Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Capricor Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Capricor Therapeutics Short Properties
Capricor Therapeutics' future price predictability will typically decrease when Capricor Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Capricor Therapeutics often depends not only on the future outlook of the potential Capricor Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Capricor Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.8 M | |
| Cash And Short Term Investments | 39.5 M |
Check out Capricor Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Capricor Stock, please use our How to Invest in Capricor Therapeutics guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Capricor Stock analysis
When running Capricor Therapeutics' price analysis, check to measure Capricor Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Capricor Therapeutics is operating at the current time. Most of Capricor Therapeutics' value examination focuses on studying past and present price action to predict the probability of Capricor Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Capricor Therapeutics' price. Additionally, you may evaluate how the addition of Capricor Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Capricor Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Capricor Therapeutics. If investors know Capricor will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Capricor Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.83) | Revenue Per Share 0.94 | Quarterly Revenue Growth 11.593 | Return On Assets (0.28) | Return On Equity (1.30) |
The market value of Capricor Therapeutics is measured differently than its book value, which is the value of Capricor that is recorded on the company's balance sheet. Investors also form their own opinion of Capricor Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Capricor Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Capricor Therapeutics' market value can be influenced by many factors that don't directly affect Capricor Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Capricor Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Capricor Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Capricor Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.